培训课件-抗血小板药物 2.pptVIP

  • 33
  • 0
  • 约3.41万字
  • 约 60页
  • 2016-09-24 发布于浙江
  • 举报
* 一项关于40,812 例心梗患者经抗栓治疗后出血风险的研究表明:联用抗凝药物和抗血小板药物的出血风险最大,单独使用阿司匹林发生出血事件的几率最低,仅2.6%。阿司匹林的出血风险明显低于其他抗栓药物。 Methods:?The authors used nationwide registries from Denmark to identify patients ages 30 years or older who had been admitted to the hospital with first-time myocardial infarction between 2000 and 2005. Prescription claims starting at hospital discharge were used to determine the regimen prescribed according to the following groups: monotherapy with aspirin, clopidogrel, or vitamin K antagonist; dual therapy with aspirin plus clopidogrel, aspirin plus vitamin K antagonist, or clopidogrel plu

文档评论(0)

1亿VIP精品文档

相关文档